Hologic announced earnings per share of $0.57 on revenue of $756.1M. Analysts polled by Investing.com anticipated EPS of $0.57 on revenue of $747.31M. That with comparison to EPS of $0.58 on revenue of $818.4M in the same period a year before. Hologic had reported EPS of $0.61 on revenue of $850.5M in the previous quarter. Analysts are expecting EPS of $0.48 and revenue of $672.69M in the upcoming quarter.
Hologic shares are up 14% from the beginning of the year , still down 11.55% from its 52 week high of $55.25 set on February 4. They are outperforming the Nasdaq (NASDAQ:NDAQ) which is down 1.38% year to date.
Hologic shares gained 3.91% in after-hours trade following the report.
Hologic’s report follows an earnings beat by J&J on April 14, who reported EPS of $2.3 on revenue of $20.69B, compared to forecasts EPS of $2.02 on revenue of $19.73B.
Pfizer had beat expectations on Tuesday with first quarter EPS of $0.8 on revenue of $12.03B, compared to forecast for EPS of $0.7 on revenue of $11.34B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar